Status:
COMPLETED
Evaluation of Enalapril Versus Placebo in Patients With Diastolic Heart Failure
Lead Sponsor:
Wake Forest University
Conditions:
Heart Failure With Preserved Ejection Fraction
Heart Failure, Congestive
Eligibility:
All Genders
60+ years
Phase:
PHASE3
Brief Summary
BACKGROUND: Exercise intolerance is the primary symptom in older patients with heart failure and preserved ejection fraction (HFPEF), however little is known regarding its mechanisms and therapy. MET...
Eligibility Criteria
Inclusion
- All participants will be 60 years of age or older.
Exclusion
- systolic dysfunction
- patients with evidence of significant ischemic or valvular heart disease
- chronic pulmonary disease.
- Participants who appear preliminarily eligible are invited to a formal screening visiting with an investigator cardiology physician. They also undergoing a rest and exercise electrocardiogram and echocardiogram and pulmonary function testing as well as blood hematology and chemistry tests.
- Final eligibility will be based upon all information available at the conclusion of the screening visits test, including hospital and outpatient records, history, physical examination, echocardiogram and exercise test.
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT01411735
Start Date
July 1 2003
End Date
July 1 2008
Last Update
November 6 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.